APA (7th ed.) Citation

Saad, F., & Hadaschik, B. (2018). Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial. The lancet. Oncology, 19(10), . https://doi.org/10.1016/S1470-2045(18)30456-X

Chicago Style (17th ed.) Citation

Saad, Fred, and Boris Hadaschik. "Effect of Apalutamide on Health-related Quality of Life in Patients with Non-metastatic Castration-resistant Prostate Cancer: An Analysis of the SPARTAN Randomised, Placebo-controlled, Phase 3 Trial." The Lancet. Oncology 19, no. 10 (2018). https://doi.org/10.1016/S1470-2045(18)30456-X.

MLA (9th ed.) Citation

Saad, Fred, and Boris Hadaschik. "Effect of Apalutamide on Health-related Quality of Life in Patients with Non-metastatic Castration-resistant Prostate Cancer: An Analysis of the SPARTAN Randomised, Placebo-controlled, Phase 3 Trial." The Lancet. Oncology, vol. 19, no. 10, 2018, https://doi.org/10.1016/S1470-2045(18)30456-X.